美国 · 平台与数据 · MarketBeat
CG Oncology (NASDAQ:CGON) Earns Buy Rating from Truist Financial

详细摘要
Truist Financial restated a "buy" rating and issued a $100.00 price objective (up from $85.00) on shares of CG Oncology in a research note on Tuesday.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)




